35% of pharmaceutical R&D expenses are invested into personnel expenses

It was observed the ratio of R&D expenses to personnel expenses, when developing a new drug, is about 35% on average.

According to the aggregation result of the R&D/personnel expense ratio of 40 listed companies by the 3^rd quarter of 2015, the average was analyzed to be 34.6%. In regards to the collective R&D expenses by the 3^rd quarter, the size was KRW 93.1 billion of the total KRW 269.3 bil...